The All India Institute of Medical Sciences (AIIMS) has announced to conduct the human trial of the coronavirus vaccine known as Covaxin. The hospital will start enrolling healthy individuals from today onwards. The approval of the trial was given on Saturday.
According to a Professor of Community Medicine few volunteers have already registered themselves for the trial session. The hospital would start screening the individuals and evaluate health conditions before vaccinating them.
Individuals willing to participate in the trial can send an SMS to or call at 7428847499.
IIMS Delhi is one of the 12 sites selected by Indian Council of Medical Research for conducting phase 1 and phase 2 of covaxin trials